A four-ingredient liquid with a clearly advertised five-vial price. The central question is the evidence and prescribing rationale for combining three PDE5 inhibitors.

4Play puts apomorphine alongside sildenafil, tadalafil and vardenafil. That makes it different from both a conventional single-ingredient tablet and a two-drug combination such as Sparks. Three of its four ingredients act in the same broad drug class. A larger ingredient list therefore adds interaction questions; it does not establish a larger clinical benefit.

Advertising disclosure. This publication is commercially affiliated with CoreAge Rx. Its placement and provider links are advertising. Details.

The ingredient count deserves a closer look

The liquid format may appeal to someone who finds tablets inconvenient. That preference is separate from whether this particular combination is appropriate. A meaningful consultation should explain why each active ingredient is included, how previous treatment was assessed, and what would prompt a different prescription.

The documented product is a four-ingredient compounded liquid supplied in 2 mL unit-dose vials. The listed delivery format is compounded sublingual liquid. FDA does not approve compounded finished products or verify their safety, effectiveness and quality before marketing. A licensed prescriber and pharmacy do not turn the compound into an FDA-approved product. FDA: Compounding and the FDA — questions and answers

Product
CoreAge Rx 4Play
Provider
CoreAge Rx
Listed ingredients
Apomorphine 2 mg + sildenafil 40 mg + tadalafil 4 mg + vardenafil 7.5 mg per listed 2 mL vial
Format
Compounded sublingual liquid

What the advertised price actually buys

The advertised five-pack contains five 2 mL vials for $114, or $22.80 per supplied vial. That is purchase arithmetic, not a recommendation to use five doses in a month. The landing page says auto-refill is optional after the first order; review the actual consent and invoice before enabling it.

Keep four numbers together: the amount due now, the quantity supplied, the period covered and the next renewal total. A monthly equivalent can make a prepaid plan look like a monthly bill. A low unit price can require a larger purchase. Neither figure tells you how often a medicine should be taken; only the prescription supplies those directions.

Advertised package
Five 2 mL vials; 10 mL total
Advertised package price
$114
Price per supplied vial
$22.80; purchase arithmetic, not use instructions
Shipping claim
Free discreet shipping, according to the landing page
Refill claim
Optional opt-in after the first order, according to the landing page

What is supported—and what remains open

The landing page advertises an approximately 10-minute activation time and a window up to 36 hours. Its own footnote ties these statements to ingredient pharmacology. We did not verify a controlled trial demonstrating those endpoints for the finished four-ingredient 4Play suspension. The timing statements should remain attributed marketing claims, not a guaranteed response.

The evidence basis identified for this review is ingredient studies and drug labels; no controlled study of the exact four-ingredient liquid verified. The remaining uncertainty concerns finished-product comparative safety, onset and incremental benefit. This distinction matters because a study can differ in strength, route, schedule, patient group or the outcome measured. A favorable result for one ingredient or regimen is not a clinical result for every product that shares its name.

Our review uses product and policy documents for commercial facts, and labels, government information and primary research for the medical context. We did not purchase or personally test this treatment, measure response times, or audit the provider’s clinical decisions. A missing matched study in this review is an evidence limit, not proof that a product never helps anyone.

The safety discussion this formula needs

PDE5 medicines can cause a dangerous blood-pressure drop with nitrates or nitrites, including recreational “poppers,” and must not be combined with riociguat. Tell the prescriber about all medicines, supplements, blood-pressure problems and heart conditions. Do not add another ED medicine or increase an amount based on an advertisement or this review. MedlinePlus: Sildenafil MedlinePlus: Tadalafil

Headache, flushing, indigestion, congestion and dizziness are among the adverse effects described for these medicines. The exact risk depends on the drug, prescription and medical history. A short list here cannot replace the complete pharmacy information or an individual assessment.

Overlapping ED medicines
The tadalafil label advises against use with other PDE5 inhibitors because combination safety and efficacy have not been established in labeling. A prescribed compound does not remove that uncertainty. DailyMed: Tadalafil prescribing information, including section 5.11
Rhythm history
Tell the prescriber about prolonged QT, relevant family history and rhythm medicines. This ingredient has specific precautions beyond a generic ED checklist. MedlinePlus: Vardenafil
Additional active ingredient
Apomorphine studies report adverse effects including nausea. Review its own interaction profile instead of relying only on a sildenafil safety summary. Dula et al. (2001): sublingual apomorphine crossover trial

What the public listing does not settle

CoreAge Rx 4Play is classified here as “publicly listed.” Public product listing; prescription and individual eligibility required. A page being online does not verify shipping to every state, current stock, eligibility, or the formula that will be dispensed to a particular patient.

An appropriate discussion starts with treatment history and the reason for this exact formula. Someone who has not yet had their symptoms or medication list assessed needs that assessment before choosing a four-drug product.

Verify before ordering
Exact product name; complete ingredients and strengths; dispensing pharmacy; state access; clinician approval
Practical distinction
A safety document can describe an older formulation without confirming a current new-customer offer.

Refills, changes and cancellation

The 4Play landing page describes a $114 first five-pack and says automatic refills are optional after the first order. It also advertises no charge unless a provider prescribes. These are provider statements, not a completed checkout or a guarantee that a particular applicant will receive a prescription. Before enabling recurring orders, retain the interval, total, cancellation steps and the next processing date shown in the account. A public statement about no long-term contracts does not explain every order-specific refund situation.

A customer-service action changes an account; a prescribing decision changes treatment. Keep both confirmations when changing plans. If symptoms or adverse effects require attention, contact the clinical team rather than waiting for the next scheduled billing event. CoreAge Rx: 4Play product information

Compare the products that differ in a meaningful way

A useful next comparison for CoreAge Rx 4Play changes one identifiable feature: the ingredient combination, the dosage form, the schedule or the provider’s commercial terms. The related reviews below make those differences visible. They are not a clinical ranking or a recommendation to substitute medicines.

Use the comparison desk to place up to three fact sheets together. The plan-cost guide explains why comparing a monthly equivalent with a per-dose headline can produce the wrong conclusion.

Questions to take to the consultation

What is the rationale for three PDE5 inhibitors in my prescription, and how will interactions and response be monitored?

Also ask what would count as a useful response, what side effects should prompt contact, who reviews an unsatisfactory result, and how a change reaches the pharmacy before the next order. Keep the answer tied to this exact prescription, not the provider’s product family.

Prescription question
Why this ingredient list, strength, route and schedule for the symptoms discussed?
Payment question
What is charged today, what renews, and when does cancellation need to be recorded?
Follow-up question
How do I reach a clinician, and what should be handled through urgent or emergency care?

When account support is not enough

Seek emergency care for an erection lasting more than four hours or chest pain. Tell the treating team which medicines were taken and when. Sudden loss of vision or hearing needs prompt medical attention; do not wait for a routine subscription-support reply. MedlinePlus: Sildenafil MedlinePlus: Tadalafil

Read the underlying material

Sources & evidence notes

Provider documents support product and commercial details. Clinical references have their own study or labeling limits. Accessed October 7, 2026; indexed abstracts were used for the listed studies.

  1. CoreAge Rx: 4Play product information

    Provider source; product description and advertised price

  2. FDA: Compounding and the FDA — questions and answers

    Government guidance on compounded medications

  3. DailyMed: Tadalafil prescribing information, including section 5.11

    Prescribing label; not evidence for the 4Play combination

  4. MedlinePlus: Sildenafil

    Drug information; standard sildenafil products

  5. MedlinePlus: Tadalafil

    Drug information; standard tadalafil products

  6. MedlinePlus: Vardenafil

    Government patient drug information; standard products, not compounded equivalents

  7. Dula et al. (2001): sublingual apomorphine crossover trial

    Primary randomized trial; single-ingredient apomorphine, abstract reviewed via NCBI

  8. Cui et al. (2015): daily tadalafil with as-needed sildenafil

    Primary clinical study; 180 patients, specific regimen, abstract reviewed via NCBI

  9. NIDDK: Diagnosis of erectile dysfunction

    Government patient information